1. Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
   Tijana Stanković et al, 2019, Current Medicinal Chemistry CrossRef
2. The role of dietary flavonoids for modulation of ATP binding cassette transporter mediated multidrug resistance
   Hui Teng et al, 2021, eFood CrossRef
3. Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma
   Keisuke Shigeta et al, 2020, Cancer Science CrossRef
4. Cepharanthine Regulates Autophagy via Activating the p38 Signaling Pathway in Lung Adenocarcinoma Cells
   Chao Wang et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
5. Pharmacological Activity of Cepharanthine
   Ke Liu et al, 2023, Molecules CrossRef
6. Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial–Mesenchymal Transition in an Ovarian Tumor
   Xi Chen et al, 2024, Journal of Natural Products CrossRef
7. Cajanol Sensitizes A2780/Taxol Cells to Paclitaxel by Inhibiting the PI3K/Akt/NF-κB Signaling Pathway
   Ming Sui et al, 2021, Frontiers in Pharmacology CrossRef
8. Natural Products in Preventing Tumor Drug Resistance and Related Signaling Pathways
   Chuansheng Yang et al, 2022, Molecules CrossRef
9. Alkaloids Exhibit a Meaningful Function as Anticancer Agents by Restraining Cellular Signaling Pathways
   Chong Guo et al, 2022, Mini-Reviews in Medicinal Chemistry CrossRef
10. Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway
    Yang-yang Lu et al, 2023, Cell Death Discovery CrossRef
11. Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines
    Chung-Pu Wu et al, 2020, Biochemical Pharmacology CrossRef
12. Pharmacological Effects and Clinical Prospects of Cepharanthine
    Di Liang et al, 2022, Molecules CrossRef
13. PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
    Alia Ghoneum et al, 2019, Cancers CrossRef
14. Unveiling the potential of Cepharanthine from plant to patient- A comprehensive review of phytochemistry, pharmacology and clinical investigations
    Swati Dobhal et al, 2024, Journal of Biologically Active Products from Nature CrossRef
15. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
    Christian Bailly, 2019, Phytomedicine CrossRef
16. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
17. Cepharanthine hydrochloride induces mitophagy targeting GPR30 in hepatocellular carcinoma (HCC)
    Yao Wang et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
18. A mechanistic updated overview on Cepharanthine as potential anticancer agent
    YingZheng Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
19. Overcoming P-Glycoprotein-Mediated Doxorubicin Resistance
    Suree Jianmongkol, 2021, Advances in Precision Medicine Oncology CrossRef
20. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review)
    Yichen Tian et al, 2023, International Journal of Oncology CrossRef
21. Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
    Rong Zhang et al, 2022, Brazilian Journal of Pharmaceutical Sciences CrossRef
22. Rhinacanthin-C enhances chemosensitivity of breast cancer cells via the downregulation of P-glycoprotein through inhibition of Akt/NF-kappa B signaling pathway
    Suwichak Chaisit et al, 2021, Journal of Herbmed Pharmacology CrossRef
23. Paclitaxel and chemoresistance
    Zhuo-Xun Wu et al, 2022, Paclitaxel CrossRef